Viewing Study NCT00623766


Ignite Creation Date: 2025-12-24 @ 4:13 PM
Ignite Modification Date: 2026-01-29 @ 5:34 AM
Study NCT ID: NCT00623766
Status: COMPLETED
Last Update Posted: 2014-06-09
First Post: 2008-02-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
Sponsor: Bristol-Myers Squibb
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords: